Theraclion aims at bringing non-invasive breakthrough therapies in todayÍs healthcare to improve many patients lives and reduce healthcare costs. A medical device company specialized in echotherapy, Theraclion offers an innovative solution combining High-Intensity Focused Ultrasound (HIFU) therapy guided by real-time ultrasound monitoring for non-invasive treatment of tumors such as breast fibroadenoma and thyroid nodules. Based in the area of Paris, France, Theraclion is supported by an international medical and scientific committee composed of surgeons, radiologists, gynecologists, endocrinologists, nephrologists and physicists, and relies on the expertise of engineers, physicians, and business people to offer medical care providers and patients, a simple efficient and safe solution.